|View printer-friendly version|
|Luminex Corporation Receives Deloitte Technology Fast 500(TM) Award|
AUSTIN, Texas, Oct. 19, 2011 /PRNewswire via COMTEX/ --
Luminex Corporation (NASDAQ: LMNX) today announced that it has been recognized in Deloitte's 2011 Technology Fast 500(TM), a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on comparing percentage revenue growth over five years from 2006-2010.
"We are pleased to be included again in the Deloitte Technology Fast 500(TM) this year," said Patrick Balthrop, president and CEO of Luminex. "Our revenue growth during this period is attributed to our pursuit of differentiated product offerings across diversified markets and channels. This achievement signifies the hard work and dedication of our Luminex team, support from our loyal customers and strategic partners and our continued dedication to transforming global healthcare."
"Luminex Corporation, like all 2011 Technology Fast 500(TM) companies, has excelled in fostering innovation and channeling it into spectacular growth - against the backdrop of one of the most challenging economies in history," said Eric Openshaw, vice chairman and U.S. technology, media and telecommunications leader, Deloitte LLP. "Deloitte recognizes Luminex for its remarkable accomplishment."
"We are pleased to honor Luminex as a 2011 Technology Fast 500(TM) company," said Mark Jensen, managing partner, technology and venture capital services, Deloitte & Touche LLP. "As one of the fastest growing tech companies in North America, Luminex has demonstrated excellence in technological innovation, entrepreneurship, and rapid growth."
For more information about Luminex Corporation, please visit our web site at www.luminexcorp.com.
About Deloitte's 2011 Technology Fast 500(TM)
Technology Fast 500, which was conducted by Deloitte & Touche LLP, a subsidiary of Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies - both public and private - in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2006 to 2010. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company's operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years, and be headquartered within North America. More information on 2011 winners of the Deloitte Technology Fast 500 Program is available at http://www.fast500.com
About Luminex Corporation
Luminex is committed to applying its passion for innovation to advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform, and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at http://www.luminexcorp.com.
SOURCE Luminex Corporation